A specialized generative AI platform for protein engineering that uses experimental lab data to fine-tune sequence predictions, making it a practical choice for R&D teams rather than just a theoretical modeling tool.
Excellent for teams with high-throughput wet lab capabilities needing to optimize protein function, weaker for researchers without proprietary experimental data to feed the models.
Analysis based on product data, pricing structure, traffic signals, and public user sentiment.
Who Should Use Cradle?
Typical users
Protein engineers, synthetic biologists, and R&D leads at biotech startups or pharmaceutical companies.
Maturity fit
scaling to advanced
Choose this if…
- You have existing experimental data to fine-tune machine learning models
- Your priority is optimizing specific protein properties like thermostability or activity
- You want to reduce the number of wet-lab iterations required to find a viable sequence
Skip this if…
- You only need static 3D structure predictions (use AlphaFold or ESMFold instead)
- You lack a wet lab to validate and iterate on AI-generated sequences
- You are looking for a low-cost or open-source academic tool
About Cradle
Cradle is a design platform for protein engineering that combines generative AI with experimental feedback loops. It helps biologists design improved proteins by predicting how sequence changes will affect physical properties. The platform is built to handle the messy, small-dataset reality of biological research.
Official profiles
What it actually does
Cradle allows users to upload protein sequences and experimental results to train custom models. These models then suggest new mutations or entire sequences optimized for specific goals like higher yield or better stability. It visualizes these predictions and manages the data flow between the digital design phase and physical lab testing.
What makes it different
Most AI tools in this space focus on structure prediction from public datasets. Cradle focuses on functional optimization using a 'human-in-the-loop' approach where the AI learns specifically from the user's proprietary lab results. This makes the suggestions increasingly accurate for a specific project over time.
Ratings across the web
Ratings aggregated from independent review platforms.
Key Features
Proprietary LLMs
Uses specialized biological language models trained on vast protein datasets to suggest viable mutations.
Active Learning Loops
Automatically updates models as you upload new experimental data from the lab.
Property Prediction
Estimates thermostability, solubility, and activity levels before you synthesize a single sequence.
Multi-parameter Optimization
Balances competing goals, such as increasing enzyme activity without sacrificing stability.
Data Workbench
Centralizes sequence data and experimental results to prevent knowledge silos in R&D teams.
Cloud-native Infrastructure
Handles the heavy compute required for generative biology without needing local GPU clusters.
Pricing
Contact Sales
- Full access to generative protein design tools
- Private model fine-tuning
- Enterprise-grade security and data isolation
- Dedicated support and onboarding
Pricing checked 4 months ago
Pricing guidance
- When moving from theoretical research to active lead optimization
- When team size grows and requires centralized data management
- When experimental throughput increases
- Compute credits may be capped depending on the contract
- Number of custom models allowed per project
- Data storage limits for high-resolution experimental results
Premium enterprise positioning targeting high-value pharmaceutical and industrial biotech sectors.
Pros & Cons
Strengths
-
Reduces experimental overhead
By narrowing down the sequence space to the most promising candidates, teams can significantly reduce the number of 'dead-end' plates they run in the lab.
-
User-friendly for non-coders
Unlike many bioinformatics tools that require Python proficiency, Cradle provides a web interface accessible to bench biologists.
-
Learns from small datasets
The platform is designed to provide value even with dozens of data points, rather than requiring the millions of entries typical of standard ML.
Weaknesses
-
Garbage in, garbage out
The accuracy of the suggestions is heavily dependent on the quality and consistency of the user's lab data.
Affects: Teams with inconsistent experimental protocols
-
High cost of entry
As an enterprise-focused SaaS, it is likely priced out of reach for individual academic researchers or very early-stage bootstrapped projects.
Affects: Academic labs and pre-seed startups
-
Niche focus
It is highly optimized for proteins; researchers working on small molecules or complex gene circuits will find it less applicable.
Affects: General synthetic biology labs
Real User Sentiment
Users in the biotech community view Cradle as a bridge between high-level AI research and practical lab application.
Users tend to like
- The intuitive interface for biologists
- The ability to incorporate negative results into the model
- Speed of generating new sequence libraries
Users commonly complain about
- Lack of transparent pricing
- The 'black box' nature of some generative suggestions
- Initial setup time to clean and format legacy data
Recurring tradeoffs
- Users trade off total control over model architecture for a streamlined, managed workflow.
Happiest users
Biotech R&D teams that have a clear target protein and a high-throughput testing pipeline already in place.
Often frustrated
Bioinformaticians who prefer to build their own custom pipelines using open-source libraries like PyTorch or BioPython.
Use Cases
Enzyme Engineering
Optimizing industrial enzymes for higher catalytic activity at specific temperatures.
Antibody Discovery
Refining antibody sequences to improve binding affinity and reduce immunogenicity.
Vaccine Development
Designing stable viral antigens for more effective vaccine formulations.
Alternative Proteins
Improving the taste, texture, or nutritional profile of lab-grown proteins.
Therapeutic Optimization
Enhancing the half-life or solubility of protein-based drugs.
Frequently Asked Questions
How much does Cradle cost?
Cradle does not publish its pricing. It follows an enterprise SaaS model where costs are negotiated based on the number of users, the volume of data, and the level of support required. Expect pricing to be in the range of mid-to-high five figures annually at minimum.
How does Cradle compare to Benchling?
Benchling is primarily an Electronic Lab Notebook (ELN) and Inventory system (LIMS) for tracking data. Cradle is a design and prediction engine. While Benchling records what you did, Cradle suggests what you should do next. They are often used together rather than as competitors.
Is my data safe and private on Cradle?
Yes, Cradle emphasizes that user data and the models fine-tuned on that data are isolated and remain the property of the customer. This is a core part of their enterprise offering to ensure pharmaceutical companies don't leak intellectual property.
Do I need to be a data scientist to use it?
No. Cradle is designed for bench biologists. The platform abstracts the complex machine learning infrastructure into a visual interface where you upload CSVs or Excel files and receive sequence suggestions.
Can Cradle predict protein structure like AlphaFold?
While Cradle's models are aware of structural principles, its primary focus is on sequence-to-function prediction. It is used to optimize how a protein behaves (e.g., its activity or stability) rather than just predicting its static shape.
What kind of data do I need to get started?
You typically need a set of protein sequences and their corresponding experimental measurements (like melting temperature, EC50, or yield). The more data points you have, the better the initial model performance will be.
Why trust this page?
This evaluation combines product positioning, pricing analysis, traffic and market signals, and public user sentiment into a single decision-support page. Content is generated editorially — not copied from the vendor's website.
Funding & Company
Founded
2021
Stage
Series b
Total Raised
$102.4M
Latest Round
Series B (Nov 2024)
Notable Investors
Cradle has raised over $102 million across three rounds, culminating in a $73 million Series B in late 2024. This significant and recent funding from top-tier investors like IVP and Index Ventures provides substantial runway and signals strong market confidence in its AI-driven protein engineering platform.
Market Signals & Traffic
Estimated visits, global rank, geography, traffic sources, monthly visit trends, and organic search keywords (Similarweb)—on a dedicated page built for depth and search.
- Estimated visits
- 0
- Global rank
- —
- Snapshot
- Apr 2026
- Traffic trend
- —
Estimated monthly visits
Alternatives to Cradle
View all alternativesSimilar Tools
Inceptive
Research, Health & Wellness
Designing novel RNA molecules for next-generation biological medicines.
Atomic AI
Research, Health & Wellness
Platform for RNA-targeted drug discovery and structural biology research
Terray Therapeutics
Research, Health & Wellness
Generative platform for large-scale small molecule drug discovery.
Profluent
Research, Health & Wellness
Generative protein design platform for creating novel functional proteins
Klu
Developer Tools, Workflow, Automation & Agents
Build, manage, and optimize applications powered by large language models.
Fashable
Design, E-commerce, Content Creation
Generative design platform for the fashion and retail industry